February 13, 2020 / 3:28 PM / 13 days ago

BRIEF-Livzon Pharmaceutical Updates On Progress Of Rerearch & Development Of Products

Feb 13 (Reuters) - Livzon Pharmaceutical Group Inc :

* DIAGNOSTICS KIT FOR IGM ANTIBODY TO NOVEL CORONAVIRUS PASSED EMERGENCY APPROVAL REPLY FOR VITRO DIAGNOSTIC REAGENTS

* DIAGNOSTICS KIT FOR IGG ANTIBODY TO NOVEL CORONAVIRUS PASSED EMERGENCY APPROVAL REPLY FOR VITRO DIAGNOSTIC REAGENTS

* DIAGNOSTICS KIT FOR IGG ANTIBODY TO NOVEL CORONAVIRUS FORMALLY ENTERED EXPEDITED APPROVAL PATHWAYS

* DIAGNOSTICS KIT FOR IGM ANTIBODY TO NOVEL CORONAVIRUS FORMALLY ENTERED EXPEDITED APPROVAL PATHWAYS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below